Article Information
History
- January 27, 2022.
Article Versions
- Version 1 (January 23, 2022 - 03:24).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Maria Krutikov, MRCP1,
- Oliver Stirrup, PhD2,
- Hadjer Nacer-Laidi, PhD1,
- Borscha Azmi, MSc1,
- Chris Fuller, MSc1,
- Gokhan Tut, PhD3,
- Tom Palmer, MSc2,
- Madhumita Shrotri, MSc1,
- Aidan Irwin-Singer, MA5,
- Verity Baynton, MA5,
- The COVID-19 Genomics UK (COG-UK) consortium,
- Andrew Hayward, MD4,6,
- Paul Moss, PhD3,
- Andrew Copas, PhD2 and
- Laura Shallcross, PhD1,†
- 1Institute of Health Informatics, University College London UK
- 2Institute for Global Health, University College London UK
- 3Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
- 4UCL Institute of Epidemiology & Health Care, UK
- 5Department of Health & Social Care, UK
- 6Health Data Research UK
- ↵†Correspondence to: Prof Laura Shallcross, UCL Institute of Health Informatics, London NW1 2DA l.shallcross{at}ucl.ac.uk
Posted January 27, 2022.
